Comparison of Patient Information Leaflet (PIL) of Cardiac Drugs Marketed by Indian Companies with the original SmPC M. PawarP. ChakrabortyP. Biswas Abstract 03 January 2013 Pages: 885 - 885
Adverse Events Supposedly Attributable to vaccination of Yellow Fever S. BentancourtM. ValseciaI. Bignone Abstract 03 January 2013 Pages: 885 - 885
Patient Exposure Information: Data Sources and Use in Signal Detection and Safety Profiling P. ChakrabortyV. PannalaP. Biswas Abstract 03 January 2013 Pages: 885 - 885
Monitoring of Hematological Safety of Leponex® (Clozapine): Results of 14 Years M. Fuentes-VargasA. Barrera-IslasF. Fon-Mendez Abstract 03 January 2013 Pages: 885 - 885
Creation of an Electronic Database for the Reporting of Adverse Events from a Drug Adherence Program A. Barrera-IslasM. Fuentes-VargasF. Fon-Mendez Abstract 03 January 2013 Pages: 885 - 885
The Effect Lipid Lowering Drugs Statins on Increasing Risk of Albuminuria and Reduce of Renal Function: A Cohort Study J. ThobariR. GansevoortL. De Jong-van Den Berg Abstract 03 January 2013 Pages: 885 - 885
Side Effects of Local Anaesthetic Drugs I. SalouageS. El AidliC. Belkahia Abstract 03 January 2013 Pages: 885 - 885
Anaphylactic Shock with Coronary Stenting Thrombosis Induced By Amoxicillin-Clavulanic Acid R. CharfiS. El AïdliC. Belkahia Abstract 03 January 2013 Pages: 885 - 885
Descriptive Study of Teratovigilance Notifications S. El AidliS. KastalliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Recurrent Fixed Drug Eruption due to Fluconazole F. CherifA. ZaïemS. El Aïdli Abstracts 03 January 2013 Pages: 885 - 885
Severe Phenytoin Intoxication with Plasmatic Monitoring R. CharfiI. SalouageC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Serious Cutaneous Reactions to Carbamazepine F. CherifS. El AïdliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Visual Disturbances Carbamazepine-Induced F. CherifS. KastalliS. El Aïdli Abstracts 03 January 2013 Pages: 885 - 885
Acyclovir Induced Sudden Coma: A Case Report F. CherifS. El AïdliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Peripheral Neuropathy during Infliximab Therapy for Rheumatoid Arthritis F. CherifS. El AïdliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Recurrent Fixed Drug Eruption due to Loratadine S. KastalliS. El AïdliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Necrosis of the Eyelids after Local Anesthesia S. KastalliS. El AïdliC. Belkahia Abstracts 03 January 2013 Pages: 885 - 885
Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina C. SantucciR. PapaleI. Bignone Abstracts 03 January 2013 Pages: 885 - 885
Off-Label Use in Expectation-Based Medicine: The Point of View of a Health Insurance Institution (Provincial Administration of Health Insurance, AProSS) L. AlessoR. HerreraR. Rodriguez Abstracts 03 January 2013 Pages: 885 - 885
Only Few Serious Adverse Drug Reactions Are Due to Drugs of Beers’ List of Inappropriate Medications for the Elderly M. RottenkolberY. PlatelP. A. Thuermann Abstracts 03 January 2013 Pages: 885 - 885
Illegitimate High Price Medicines in Argentina in 2008 L. AlessoR. RodriguezR. Herrera Abstracts 03 January 2013 Pages: 885 - 885
Lack of Efficacy of Anesthetics in Public Hospitals of Cordoba, Argentina K. GaticaS. LizzioV. Dabbene Abstracts 03 January 2013 Pages: 885 - 885
Admissions by Bleeding or High INR Caused by Drugs in a Private Non-Profit Hospital, Montevideo, Uruguay L. OlmosG. GiachettoJ. Gesto Abstracts 03 January 2013 Pages: 885 - 885
Retrospective Analysis of Pharmacy Dispensing Errors: Twelve Years Experience in a UK Hospital A. R. CoxS. PhullR. E. Ferner Abstracts 03 January 2013 Pages: 885 - 885
Development of Guideline and Macro Flow for Brazilian System of Pharmacovigilance: Basis for Decentralization M. O. BittencourtM. F. DiasF. C. S. Cruz Abstracts 03 January 2013 Pages: 885 - 885
Adverse Drug Reaction (ADR) Related to Sertraline in a Breastfeeding Infant through Maternal Exposure: Case Report M. Morales Díaz Abstracts 03 January 2013 Pages: 885 - 885
Risk of Myocardial Infarction (MI) and Non Aspirin Non Steroidal Anti-Inflammatory Drugs (NANSAIDs): Analysis of a Depletion of Susceptibles Effect in the Risk of MI with Diclofenac: A Field Case-Control Study with the PGRx System L. Bensouda-GrimaldiM. RossignolL. Abenhaim Abstracts 03 January 2013 Pages: 885 - 885
Assessment of Medication Error Reports Sent to Brazilian Medicine Monitoring Centre (CNMM) M. O. BittencourtS. C. C. LuizM. F. Dias Abstracts 03 January 2013 Pages: 885 - 885
Pharmaceutical Care Practice: A Useful Tool in Pharmacovigilance V. Pino SalomónY. Medina Berroteran Abstracts 03 January 2013 Pages: 885 - 885
Protocol Writing: Requirements for Academic Sponsors in Terms of Safety D. BertramA. ChiffoleauE. Devilliers Abstracts 03 January 2013 Pages: 885 - 885
Inventing a Drug Safety Program for Psychiatric Inpatients: AMSP (Arzneimittelsicherheit in der Psychiatrie) A. KonstantinidisR. GrohmannS. Kasper Abstracts 03 January 2013 Pages: 885 - 885
“Off-Label Use” of Second Generation Antipsychotics in an Austrian Inpatient Population — Data from the Austrian AMSP A. KonstantinidisU. MoserS. Kasper Abstracts 03 January 2013 Pages: 885 - 885
Strategies Impact to Increase the Reporting of Pharmacovigilance in a Brazilian University Hospital H. C. CapuchoL. V. ReisL. R. L. Pereira Abstracts 03 January 2013 Pages: 885 - 885
Adverse Reactions to Drugs: Profile of University Hospital’s Notifications of the Brazilian Network of Sentinel Hospitals H. C. CapuchoNd. O. Costa Abstracts 03 January 2013 Pages: 885 - 885
Incidence and Risk Factors for Agranulocytosis in Argentina: Results of a Substudy D. GoldenbergC. MarinA. Goldenberg Abstracts 03 January 2013 Pages: 885 - 885
Allergy-Immune Profile of High Risk Patients for Low Osmolality Contrast Media (LOCM) Adverse Drug Reactions (ADRs): A Basis for Prevention G. DozoM. T. SerraL. Alesso Abstracts 03 January 2013 Pages: 885 - 885
Diagnosis Tests for Diagnosing Allergic Contact Dermatitis in the Prevention of Adverse Reactions to Topic Medicines M. T. Serra CriscuoloG. DozoL. Alesso Abstracts 03 January 2013 Pages: 885 - 885
10 Years of Experiences with Consumer Reporting to KILEN — A Swedish Consumer Organisation L. WestinJ. Albinson Abstracts 03 January 2013 Pages: 885 - 885
Consumers and Health Care Professionals Differences in Reporting Trend: A Register-Based Study of Danish Adverse Drug Reactions Reports (2004–2006) L. AagaardL. H. NielsenE. H. Hansen Abstracts 03 January 2013 Pages: 885 - 885
Evaluation and Comparison of Two Methods of Causality Assessment in an Italian Spontaneous Reporting Database G. VeloM. DonatiU. Moretti Abstracts 03 January 2013 Pages: 885 - 885
The Adverse Medicine Events (AME) Line: Australian Experience with Consumer Pharmacovigilance G. MosesT. McGuireJ. McEwen Abstracts 03 January 2013 Pages: 885 - 885